Alar Pharmaceuticals (ROCO:6785) Minority Interest: NT$0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6785 Alar Pharmaceuticals Inc ROCO:6785
51 GF Score
Price NT$99.20
GF Value NT$91.62
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Alar Pharmaceuticals Minority Interest?

Alar Pharmaceuticals ROCO:6785 +0.92% 51 Minority Interest is NT$0.00 Mil as of Jun. 2026. GuruFocus rates ROCO:6785 with a GF Score™ of 51/100 and a GF Value™ of NT$91.62 (Fairly Valued). The stock has 1 warning sign investors should review.

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Alar Pharmaceuticals's minority interest for the quarter that ended in Jun. 2026 was NT$0.00 Mil.

Alar Pharmaceuticals Minority Interest Historical Data

* Premium members only.

The historical data trend for Alar Pharmaceuticals's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alar Pharmaceuticals Minority Interest Chart

Alar Pharmaceuticals Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Minority Interest
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Alar Pharmaceuticals Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Minority Interest Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6785
51GF Score
Alar Pharmaceuticals Inc ROCO:6785
Minority Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alar Pharmaceuticals Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Frequently Asked Questions Learn more about Minority Interest →
What does a Minority Interest of NT$0.00 Mil mean?
Alar Pharmaceuticals (ROCO:6785) has a Minority Interest of NT$0.00 Mil as of Jun. 2026. Minority interest represents the carrying value of equity from non-controlling shareholders and company partners. View historical data on Alar Pharmaceuticals.
Is Alar Pharmaceuticals' Minority Interest too high?
Alar Pharmaceuticals' current Minority Interest is NT$0.00 Mil. Overall, Alar Pharmaceuticals has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alar Pharmaceuticals' Minority Interest compare to ZTS?
Alar Pharmaceuticals' Minority Interest of NT$0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Minority Interest for a Drug Manufacturers company?
A good Minority Interest depends on the Drug Manufacturers industry context. However, Minority Interest should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Minority Interest mean?
A high Minority Interest can signal that a stock is expensive relative to its fundamentals. Minority interest represents the carrying value of equity from non-controlling shareholders and company partners. View historical data on Alar Pharmaceuticals. Alar Pharmaceuticals's current Minority Interest is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alar Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Alar Pharmaceuticals (ROCO:6785) is currently considered Fairly Valued. The stock's GF Value™ is NT$91.62, compared to a current price of NT$99.20 — trading 8.3% above its estimated fair value. The current Minority Interest is NT$0.00 Mil. Alar Pharmaceuticals' overall GF Score™ is 51/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Minority Interest calculated?
Minority Interest is calculated from a company's financial statements. For Alar Pharmaceuticals (ROCO:6785), the current Minority Interest is NT$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alar Pharmaceuticals (ROCO:6785) Overvalued in 2026?

Based on GuruFocus' analysis, Alar Pharmaceuticals stock appears to be overvalued. The current stock price of NT$99.20 is trading 8.3% above its estimated GF Value™ of NT$91.62. GuruFocus considers Alar Pharmaceuticals to be Fairly Valued.

Key valuation signals for ROCO:6785:

  • Minority Interest: NT$0.00 Mil
  • GF Value™: NT$91.62 vs. price of NT$99.20 (8.3% above fair value)
  • GF Score™: 51/100 with 1 warning sign

No single metric tells the full story. See the ROCO:6785 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alar Pharmaceuticals Business Description

Address Jhongke Road, No. 32, No. 2, 5th Floor, Situn District, Taichung, TWN, 428015
Alar Pharmaceuticals Inc is a drug development company mainly engaged in the research and development of new drugs, sales of western pharmaceuticals, and medical devices. It focuses on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorder, chronic pain, and depressive disorder. The company currently has only a new drug development division, and its product pipeline comprises various drug candidates such as ALA-1000 (Buprenorphine), ALA-1300, ALA-2000 (Naltrexone), ALA-3000 (Ketamine), ALA-4000 (Apomorphine), and ALA-5000 (Third-generation antipsychotic). Geographically, the company generates maximum revenue from the USA and also has its presence in Taiwan and the United Kingdom.
51GF Score

Get the complete analysis for ROCO:6785

Minority Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$99.20
Price
NT$91.62
GF Value